Anticoagulants and Their Reversal
- 13 December 2006
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 21 (1) , 37-48
- https://doi.org/10.1016/j.tmrv.2006.08.002
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Risk of Hemorrhage Among Patients With Warfarin-Associated CoagulopathyJournal of the American College of Cardiology, 2006
- Nucleic acid aptamers in therapeutic anticoagulationThrombosis and Haemostasis, 2005
- Recombinant Factor VIIa for Rapid Reversal of Warfarin Anticoagulation in Acute Intracranial HemorrhageMayo Clinic Proceedings, 2004
- Recombinant Platelet Factor 4 for Heparin NeutralizationSeminars in Thrombosis and Hemostasis, 2004
- A novel long‐acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A Phase II evaluationJournal of Thrombosis and Haemostasis, 2004
- Effect of recombinant factor VIIa on melagatran-induced inhibition of thrombin generation and platelet activation in healthy volunteersThrombosis and Haemostasis, 2004
- Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole bloodThrombosis and Haemostasis, 2004
- The impact on coagulation of an intravenous loading dose in addition to a subcutaneousregimen of low-molecular-weight heparinin the initial treatment of acute coronary syndromesJournal of the American College of Cardiology, 2003
- The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findingsJournal of Neurosurgery, 2003
- Synthetic Heparin Pentasaccharide Depolymerization by Heparinase 1: Molecular and Biological ImplicationsClinical and Applied Thrombosis/hemostasis, 2001